Literature DB >> 10908595

Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus.

A F Hottinger1, M Azzouz, N Déglon, P Aebischer, A D Zurn.   

Abstract

To date, delivery of neurotrophic factors has only allowed to transiently protect axotomized facial motoneurons against cell death. In the present report, long-term protection of these neurons was evaluated by continuously expressing the neurotrophic factor glial cell line-derived neurotrophic factor (GDNF) within the facial nucleus using a lentiviral vector system. The viral vector was injected unilaterally into the facial nucleus of 4-month-old Balb/C mice. In contrast to axotomy in other adult rodents, facial nerve lesion in these animals leads to a progressive and sustained loss and/or atrophy of >50% of the motoneurons. This model thus represents an attractive model to evaluate potential protective effects of neurotrophic factors for adult-onset motoneuron diseases, such as amyotrophic lateral sclerosis. One month after unilateral lentiviral vector injection, the facial nerve was sectioned, and the animals were killed 3 months later. Viral delivery of the GDNF gene led to long-term expression and extensive diffusion of GDNF within the brainstem. In addition, axotomized motoneurons were completely protected against cell death, because 95% of the motoneurons were present as demonstrated by both Nissl staining and choline acetyltransferase immunoreactivity. Furthermore, GDNF prevented lesion-induced neuronal atrophy and maintained proximal motoneuron axons, despite the absence of target cell reinnervation. This is the first evidence that viral-mediated delivery of GDNF close to the motoneuron cell bodies of the facial nucleus of adult mice can lead to complete and long-term protection against lesion-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908595      PMCID: PMC6772542     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

1.  Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.

Authors:  P A Lapchak; P J Miller; F Collins; S Jiao
Journal:  Neuroscience       Date:  1997-05       Impact factor: 3.590

Review 2.  Axotomy-induced neuronal death during development.

Authors:  W D Snider; J L Elliott; Q Yan
Journal:  J Neurobiol       Date:  1992-11

3.  Estimation of nuclear population from microtome sections.

Authors:  M ABERCROMBIE
Journal:  Anat Rec       Date:  1946-02

4.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Authors:  N Déglon; J L Tseng; J C Bensadoun; A D Zurn; Y Arsenijevic; L Pereira de Almeida; R Zufferey; D Trono; P Aebischer
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

5.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Regulation of spinal motoneuron survival by GDNF during development and following injury.

Authors:  L J Houenou; R W Oppenheim; L Li; A C Lo; D Prevette
Journal:  Cell Tissue Res       Date:  1996-11       Impact factor: 5.249

7.  Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo.

Authors:  V E Koliatsos; R E Clatterbuck; J W Winslow; M H Cayouette; D L Price
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

8.  Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo.

Authors:  R Vejsada; Y Sagot; A C Kato
Journal:  Eur J Neurosci       Date:  1995-01-01       Impact factor: 3.386

9.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons.

Authors:  Q Yan; C Matheson; O T Lopez
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

10.  Infusion of GDNF into the cerebral spinal fluid through two different routes: effects on body weight and corticospinal neuron survival.

Authors:  K M Giehl; C M Schacht; Q Yan; P Mestres
Journal:  Neuroreport       Date:  1998-08-24       Impact factor: 1.837

View more
  48 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

2.  The first cysteine-rich domain of the receptor GFRalpha1 stabilizes the binding of GDNF.

Authors:  Heidi Virtanen; Jianmin Yang; Maxim M Bespalov; Jukka O Hiltunen; Veli-Matti Leppänen; Nisse Kalkkinen; Adrian Goldman; Mart Saarma; Pia Runeberg-Roos
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

3.  Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

Authors:  M E Emborg; J Moirano; J Raschke; V Bondarenko; R Zufferey; S Peng; A D Ebert; V Joers; B Roitberg; J E Holden; J Koprich; J Lipton; J H Kordower; P Aebischer
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

4.  Gene transfer engineering for astrocyte-specific silencing in the CNS.

Authors:  N Merienne; A Delzor; A Viret; N Dufour; M Rey; P Hantraye; N Déglon
Journal:  Gene Ther       Date:  2015-06-05       Impact factor: 5.250

5.  Loss of Neuronal Phenotype and Neurodegeneration: Effects of T Lymphocytes and Brain Interleukin-2.

Authors:  Danielle Meola; Zhi Huang; Grace K Ha; John M Petitto
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-06

6.  Motor Neurons Exhibit Sustained Loss of Atrophy Reversal in Immunodeficent Mice.

Authors:  Zhi Huang; John M Petitto
Journal:  J Neurol Disord       Date:  2013

7.  Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.

Authors:  Matteo Caleo; Matteo Spinelli; Francesca Colosimo; Ivica Matak; Ornella Rossetto; Zdravko Lackovic; Laura Restani
Journal:  J Neurosci       Date:  2018-10-12       Impact factor: 6.167

8.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors:  C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

9.  ESTROGEN REPLACEMENT THERAPY FOR STROKE.

Authors:  Mibel Pabon; Cyrus Tamboli; Sarosh Tamboli; Sandra Acosta; Ike De La Pena; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10

10.  Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake.

Authors:  Corinne Beurrier; Mathilde Faideau; Khaled-Ezaheir Bennouar; Carole Escartin; Lydia Kerkerian-Le Goff; Gilles Bonvento; Paolo Gubellini
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.